ROLSIGMA

Minerva Neurosciences, Inc.

Application Filed: 2019-03-11
Trademark Application Details
Trademark Logo ROLSIGMA

Mark For: ROLSIGMA™ trademark registration is intended to cover the categories of pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors. [all]

Status

2020-07-20 UTC
LIVE APPLICATION Under Examination
The trademark application has been accepted by the Office (has met the minimum filing requirements) and that this application has been assigned to an examiner.


Research OneLook Acronym Finder
Serial Number88333797
Mark Literal ElementsROLSIGMA
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2019-08-27
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 006: Chemicals and Chemical Compositions
  • 018: Medicines and Pharmaceutical Preparations
  • 044: Dental, Medical and Surgical Appliances
  • 046: Foods and Ingredients of Foods
  • 051: Cosmetics and Toilet Preparations
  • 052: Detergents and Soaps
Primary International Class
  • 005 - Primary Class
  • (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameJeffrey H. Greene
Law Office AssignedM10
Employee NameHARDY LUDLOW, TARAH KI

Timeline

2019-03-11Application Filed
2019-07-02Published
2019-07-02Published for Opposition
2019-08-27Location: INTENT TO USE SECTION
2019-08-27Status: Live/Pending
2019-12-30Transaction Date
2020-01-17Status: A first request for extension of time to file a Statement of Use has been granted.

Trademark Parties (Applicants & Owners)

Party: Minerva Neurosciences, Inc.
Address1601 Trapelo Road, Suite 286 Waltham, MASSACHUSETTS UNITED STATES 02451
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Documents

DrawingJPEG2019-03-11
TEAS RF New ApplicationMULTI2019-03-11
Notation to FileXML2019-05-07
XSearch Search SummaryXML2019-05-07
Examiners AmendmentXML2019-05-09
Notation to FileXML2019-05-09
Amendment and Mail Process CompleteMULTI2019-05-10
TRAM Snapshot of App at Pub for OppostnAPPLICATION/XML,IMAGE/JPEG2019-05-14
Notice of PublicationXML2019-06-12
Notification Of Notice of PublicationXML2019-06-12
OG Publication ConfirmationAPPLICATION/XML2019-07-02
Notice of AllowanceAPPLICATION/XML2019-08-27
TEAS Rev, App and/or COA of Atty/Dom.RepAPPLICATION/XML2019-12-30
Extension of Time to File SOUAPPLICATION/XML2020-01-17
ITU Extension ApprovalXML2020-01-21
ITU Unit ActionAPPLICATION/XML,IMAGE/JPEG2020-01-21

Attorney of Record

Jeffrey H. Greene
Cooley LLP
Suite 700
1299 Pennsylvania Ave., NW
Washington DC 20004

Good, Services, and Codes


IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors

International Codes:5
U.S. Codes:006,018,044,046,051,052
Type CodeType
GS0051Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors

Trademark Filing History

DescriptionDateProceeding Number
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED2020-01-21
TEAS EXTENSION RECEIVED2020-01-17
EXTENSION 1 GRANTED2020-01-1798765
EXTENSION 1 FILED2020-01-1798765
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED2019-12-30
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED2019-12-30
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2019-08-27
PUBLISHED FOR OPPOSITION2019-07-02
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2019-07-02
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2019-06-12
ASSIGNED TO LIE2019-05-2874221
APPROVED FOR PUB - PRINCIPAL REGISTER2019-05-13
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2019-05-096328
EXAMINERS AMENDMENT E-MAILED2019-05-096328
EXAMINERS AMENDMENT -WRITTEN2019-05-0976509
EXAMINER'S AMENDMENT ENTERED2019-05-0988888
ASSIGNED TO EXAMINER2019-05-0776509
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2019-03-28
NEW APPLICATION ENTERED IN TRAM2019-03-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed